23 reports

Global Esophageal Cancer Epidemiology and Patient Flow Analysis - 2017 ##.

  • Esophageal Cancer
  • France
  • United States
  • World
  • Forecast

Oesophageal Cancer Phase ## Clinical Trials, 2016 ##.

  • Esophageal Cancer
  • France
  • Germany
  • United States
  • Market Size

Esophageal Cancer - Epidemiology Forecast to 2027 ##.

  • Esophageal Cancer
  • France
  • Germany
  • Italy
  • Spain

Europe Esophageal Cancer Epidemiology and Patient Flow Analysis - 2017 ##.

  • Esophageal Cancer
  • Europe
  • France
  • Germany
  • Forecast
  • Incidence of Oesophageal Cancer, total (000s)
  • TOP-LINE INCIDENCE FOR OESOPHAGEAL CANCER

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Oesophageal Cancer in 18 Major Markets Oesophageal Cancer is an uncontrolled growth of abnormal cells which forms in the lining of the oesophagus. Epithelial tumours of the oesophagus are responsible for the majority of oesophageal cancers. The majority of oesophageal...

  • Cancer
  • Esophageal Cancer
  • Pathology

Esophageal Cancer - Market Insight, Epidemiology and Market Forecast - 2027 ##.

  • Cancer
  • Esophageal Cancer
  • Pathology
  • United States
  • Market Shares

Oesophageal Cancer Phase ## Clinical Trials, 2016 ##.

  • Esophageal Cancer
  • France
  • Germany
  • Italy
  • Market Size

Oesophageal Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Esophageal Cancer
  • Pathology
  • United States
  • Market Size

Oesophageal Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Esophageal Cancer
  • Pathology
  • Japan
  • Market Size

Oesophageal Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Esophageal Cancer
  • Pathology
  • Germany
  • Market Size

Oesophageal Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Esophageal Cancer
  • Pathology
  • France
  • Market Size

Oesophageal Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Esophageal Cancer
  • Pathology
  • Italy
  • Market Size

Oesophageal Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Esophageal Cancer
  • Pathology
  • United Kingdom
  • Market Size

Oesophageal Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Esophageal Cancer
  • Pathology
  • Spain
  • Market Size
  • BIOMARKER PANEL - ESOPHAGEAL CANCER BIOMARKER PANEL - ESOPHAGEAL CANCER PRODUCT OVERVIEW
  • BIOMARKER PANEL - ESOPHAGEAL CANCER - PRODUCT STATUS

Summary Proteome Sciences Plc (Proteome Sciences) is a life sciences company that delivers content for personalized medicine in various areas such as biomarker assays, isobaric and isotopic reagents, biomarker services and proprietary biomarkers. The company specializes in providing proteomics and peptidomics services and applications,...

  • Biomarker
  • Dementia
  • Esophageal Cancer
  • Genomics
  • GlobalData's company
  • LATEST CLINICAL TRIALS NEWS ON ESOPHAGEAL CANCER
  • ESOPHAGEAL CANCER THERAPEUTICS, G7 COUNTRIES, CLINICAL TRIALS BY TRIAL STATUS, 2017*

Esophageal Cancer Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Esophageal Cancer Global Clinical Trials Review, H2, 2017" provides an overview of Esophageal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Esophageal Cancer....

  • Cancer
  • Clinical Trial
  • Esophageal Cancer
  • World
  • Product Initiative
  • Esophageal Cancer - Discontinued Products
  • Esophageal Cancer - Overview

Esophageal Cancer - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Esophageal Cancer - Pipeline Review, H1 2018, provides an overview of the Esophageal Cancer (Oncology) pipeline landscape. Esophageal cancer is cancer that...

  • Esophageal Cancer
  • Monoclonal Antibody
  • North America
  • United States
  • Product Initiative

Market Spotlight: Esophageal Cancer CONTENTS ## OVERVIEW ## KEY TAKEAWAYS ## DISEASE BACKGROUND ## TREATMENT ## Surgery ## Radiation therapy ## Endoscopic therapy ## Chemotherapy ## Targeted therapy ## Immunotherapy ## EPIDEMIOLOGY ## MARKETED DRUGS ## Approvals by country ## APPENDIX LIST

  • Cancer
  • Esophageal Cancer
  • Pathology
  • United States
  • World
  • Esophageal Cancer - Discontinued Products
  • Esophageal Cancer - Overview

Esophageal Cancer - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Esophageal Cancer - Pipeline Review, H2 2017, provides an overview of the Esophageal Cancer (Oncology) pipeline landscape. Esophageal cancer is cancer that occurs in the esophagus....

  • Esophageal Cancer
  • Oncology
  • Therapy
  • United States
  • Product Initiative
  • Esophageal Cancer, Head And Neck Cancer, Lung Cancer
  • Esophageal Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2016*

Esophageal Cancer Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Esophageal Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Esophageal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Esophageal Cancer. Report...

  • Clinical Trial
  • Drug Discovery And Development
  • Esophageal Cancer
  • World
  • Product Initiative

Oesophageal Cancer Pipeline Highlights – 2017 ##.

  • Cancer
  • Esophageal Cancer
  • Pathology
  • United States
  • Product Initiative
  • Therapy Area Indication(s)
  • Clinical Trial profile. 251 Trial Title

Gastroesophageal (GE) Junction Carcinomas Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Gastroesophageal (GE) Junction Carcinomas Global Clinical Trials Review, H2, 2017" provides an overview of Gastroesophageal (GE) Junction Carcinomas clinical trials scenario. This report provides...

  • Clinical Trial
  • Esophageal Cancer
  • Lung Cancer
  • World
  • Product Initiative
  • DIAGNOSTIC ASSAY - ESOPHAGEAL CANCER
  • Diagnostic Assay - Esophageal Cancer - Product Status

Summary Orion Genomics LLC (Orion Genomics) is a medical device company that manufactures and markets diagnostic products. The company offers diagnostic products such as colon cancer risk test systems, bladder cancer screening systems, lung cancer screening systems and biomarker pipeline products. Its biomarker pipeline products...

  • Breast Cancer
  • Cancer
  • Esophageal Cancer
  • Genomics
  • Orion Genomics LLC